Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
News-Medical.Net on MSN
Palbociclib improves progression-free survival in HER2 positive breast cancer
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...
Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results